血管性血友病合并大量月经出血妇女术中出血的预防和治疗策略:系统综述

IF 6.9 2区 医学 Q1 HEMATOLOGY
H.P. Eising , M.C. Punt , J.C. Leemans , M.Y. Bongers
{"title":"血管性血友病合并大量月经出血妇女术中出血的预防和治疗策略:系统综述","authors":"H.P. Eising ,&nbsp;M.C. Punt ,&nbsp;J.C. Leemans ,&nbsp;M.Y. Bongers","doi":"10.1016/j.blre.2023.101131","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Optimal peri-operative management for women with Von Willebrand disease<span> (VWD) and heavy menstrual bleeding (HMB) remains undetermined.</span></p></div><div><h3>Aim and methods</h3><p>To evaluate (pre)operative management in relation to (post)operative bleeding after endometrial ablation<span> (EA) and hysterectomy in VWD women with HMB by performing a database search between 1994 and 2023.</span></p></div><div><h3>Results</h3><p>Eleven cohort studies<span> and 1 case-report were included, of overall ‘low’ quality, describing 691 operative procedures. Prophylaxis (Desmopressin, clotting factor concentrates or tranexamic acid) to prevent bleeding was described in 100% (30/30) of EA procedures and in 4% (24/661) of hysterectomies. Bleeding complications despite prophylaxis were described in 13% (3/24) of hysterectomies vs 0% (0/30) in EA.</span></p></div><div><h3>Conclusion</h3><p>VWD women often seem to experience bleeding complications during hysterectomy and all women with VWD received preprocedural hemostatic agents during EA, indicating potential under- and overdosing of current prophylactic strategies. Prospective studies are needed to determine the optimal (pre)operative strategy for gynecological surgical procedures in women with VWD.</p></div>","PeriodicalId":56139,"journal":{"name":"Blood Reviews","volume":null,"pages":null},"PeriodicalIF":6.9000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prophylactic and therapeutic strategies for intraoperative bleeding in women with von Willebrand disease and heavy menstrual bleeding: A systematic review\",\"authors\":\"H.P. Eising ,&nbsp;M.C. Punt ,&nbsp;J.C. Leemans ,&nbsp;M.Y. Bongers\",\"doi\":\"10.1016/j.blre.2023.101131\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Optimal peri-operative management for women with Von Willebrand disease<span> (VWD) and heavy menstrual bleeding (HMB) remains undetermined.</span></p></div><div><h3>Aim and methods</h3><p>To evaluate (pre)operative management in relation to (post)operative bleeding after endometrial ablation<span> (EA) and hysterectomy in VWD women with HMB by performing a database search between 1994 and 2023.</span></p></div><div><h3>Results</h3><p>Eleven cohort studies<span> and 1 case-report were included, of overall ‘low’ quality, describing 691 operative procedures. Prophylaxis (Desmopressin, clotting factor concentrates or tranexamic acid) to prevent bleeding was described in 100% (30/30) of EA procedures and in 4% (24/661) of hysterectomies. Bleeding complications despite prophylaxis were described in 13% (3/24) of hysterectomies vs 0% (0/30) in EA.</span></p></div><div><h3>Conclusion</h3><p>VWD women often seem to experience bleeding complications during hysterectomy and all women with VWD received preprocedural hemostatic agents during EA, indicating potential under- and overdosing of current prophylactic strategies. Prospective studies are needed to determine the optimal (pre)operative strategy for gynecological surgical procedures in women with VWD.</p></div>\",\"PeriodicalId\":56139,\"journal\":{\"name\":\"Blood Reviews\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2023-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0268960X23000929\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0268960X23000929","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:对于患有血管性血友病(VWD)和大量月经出血(HMB)的女性,最佳围手术期处理方法仍未确定。目的和方法通过1994年至2023年的数据库检索,评估VWD合并HMB患者子宫内膜消融(EA)和子宫切除术后出血的术前处理。结果纳入6项队列研究和1例病例报告,总体质量“低”,描述了691例手术。100%(30/30)的EA手术和4%(24/661)的子宫切除术都采用了预防出血的方法(去氨加压素、凝血因子浓缩物或氨甲环酸)。13%(3/24)的子宫切除术患者有出血并发症,而0%(0/30)的子宫切除术患者有出血并发症。结论子宫切除术患者在子宫切除术过程中经常出现出血并发症,所有子宫切除术患者在手术前都使用了止血药物,这表明目前的预防策略可能不足或过量。需要前瞻性研究来确定VWD女性妇科手术的最佳(术前)策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Prophylactic and therapeutic strategies for intraoperative bleeding in women with von Willebrand disease and heavy menstrual bleeding: A systematic review

Background

Optimal peri-operative management for women with Von Willebrand disease (VWD) and heavy menstrual bleeding (HMB) remains undetermined.

Aim and methods

To evaluate (pre)operative management in relation to (post)operative bleeding after endometrial ablation (EA) and hysterectomy in VWD women with HMB by performing a database search between 1994 and 2023.

Results

Eleven cohort studies and 1 case-report were included, of overall ‘low’ quality, describing 691 operative procedures. Prophylaxis (Desmopressin, clotting factor concentrates or tranexamic acid) to prevent bleeding was described in 100% (30/30) of EA procedures and in 4% (24/661) of hysterectomies. Bleeding complications despite prophylaxis were described in 13% (3/24) of hysterectomies vs 0% (0/30) in EA.

Conclusion

VWD women often seem to experience bleeding complications during hysterectomy and all women with VWD received preprocedural hemostatic agents during EA, indicating potential under- and overdosing of current prophylactic strategies. Prospective studies are needed to determine the optimal (pre)operative strategy for gynecological surgical procedures in women with VWD.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Blood Reviews
Blood Reviews 医学-血液学
CiteScore
13.80
自引率
1.40%
发文量
78
期刊介绍: Blood Reviews, a highly regarded international journal, serves as a vital information hub, offering comprehensive evaluations of clinical practices and research insights from esteemed experts. Specially commissioned, peer-reviewed articles authored by leading researchers and practitioners ensure extensive global coverage across all sub-specialties of hematology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信